AMA on health claims
This article was originally published in The Tan Sheet
Executive Summary
American Medical Association "strongly opposes" FDA's decision to "allow a lower standard - the so-called weight of the scientific evidence standard - to be used in deciding whether a health claim can be placed on the labeling of a conventional food product," according to Feb. 21 comments. The "weight of the scientific evidence standard" would allow the use of health claims "that have a reasonable chance of being erroneous" and "actually could confuse consumers" rather than help them to make informed decisions, the medical group contends. Comments respond to FDA's decision to no longer hold health claims for food, supplements to significant scientific agreement standard (1"The Tan Sheet" Dec. 23, 2002, p. 10). AMA also says it is working with Congress to modify DSHEA...
You may also be interested in...
Qualified Health Claims “Reasonable Consumer” Standard Adopted By FDA
FDA will employ a "reasonable consumer" standard, rather than an "ignorant, unthinking and credulous" consumer standard, to determine whether dietary supplement and food labeling is misleading, the agency announced Dec. 18
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.